DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Sandborn WJ, Colombel JF, Frankel M et al.
Anti-CD3 antibody visilizumab is not effective in patients with intravenous corticosteroid-refractory ulcerative colitis.
Gut 2010;
59: 1485-1492
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.